Alcohol Consumption and Cardiovascular Disease: A Narrative Review of Evolving Perspectives and Long-Term

Ovidiu Stefan Georgescu1, Liviu Martin2, Georgică Costinel Târtea3

  • 1Doctoral School, University of Medicine and Pharmacy of Craiova, 2 Petru Rares Str., 200349 Craiova, Romania.

Life (Basel, Switzerland)
|September 28, 2024
PubMed

Insights

Alcohol

Area of Science:

  • Cardiology
  • Public Health
  • Toxicology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of death globally.
  • Alcohol consumption is a significant lifestyle factor influencing cardiovascular health.
  • The impact of alcohol on CVDs is complex, with both potential benefits and serious risks.

Purpose of the Study:

  • To comprehensively analyze the multifaceted effects of alcohol on cardiovascular health.
  • To examine the evolution of medical understanding regarding alcohol's cardiovascular impact.
  • To explore genetic, gender, and recent paradigm shifts in this field.

Main Methods:

  • Interpretative narrative review methodology.
  • Analysis of studies on genetic risk factors and gender differences.
  • Examination of recent shifts in understanding alcohol's cardiovascular effects.

Main Results:

  • Moderate alcohol intake may offer minor lipid profile improvements.
  • Excessive alcohol consumption is linked to severe conditions like cardiomyopathy, hypertension, and arrhythmias.
  • Understanding alcohol's role requires considering genetic and gender-specific factors.

Conclusions:

  • A thorough understanding of alcohol's cardiovascular effects is crucial for public health and clinical practice.
  • Integrating alcohol consumption into cardiovascular risk management is essential.
  • Further research is needed to refine guidelines and clinical approaches.

Related Concept Videos

Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K